Caladrius Biosciences (CLBS) stock forecast for 2022 – 2027

Are you interested in Caladrius Biosciences, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CLBS stock price in 2022-2027. Is CLBS a good long term stock? When should I take profit in Caladrius Biosciences stock? Buy or sell stock? Will CLBS stock price go up? What are analysts’ forecasts for CLBS stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CLBS stock returns are also predicted based on historical data.

According to our research, CLBS stock is a bad long-term investment. CLBS share price has been in a bear cycle for the past year. Caladrius Biosciences, Inc. stock trend is negative.

Caladrius Biosciences company info

Industry Biotechnology
Address 110 Allen Road, Basking Ridge, NJ, 07920, United States
Website https://www.caladrius.com

Forecasting

52 Week High: 17.2392 USD
52 Week Low: 0.0000000196 USD
1 Year Forecast: 0.00000002 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 46.32M
52 Week Change: -1.252%
52 Week High: 3.05 USD
52 Week Low: 0.725 USD
Beta: 0.899841
50 Day Moving Average: 0.8736
90 Day Moving Average: 0.913
200 Day Moving Average: 1.13
Resistance Level: 0.83123
Pivot Point: 0.76131
Support Level: 0.70983
Enterprise Value: -38,479,748
Forward P/E: -1.59
Forward EPS: -0.46
Profit Margin: 0.00%
Shares Outstanding: 59,779,900
EBITDA: 1.39
Held Percent Institutions: 30.77%
PEG Ratio (5Y): -0.03
Trailing EPS: -0.577

Caladrius Biosciences stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Caladrius Biosciences Stock Forecast for 2022

March 2022 0 4 0%
April 2022 4 11.76 194%
May 2022 14 16.16 15.43%
June 2022 16 9.8 -38.75%
July 2022 10.2 7 -31.37%
August 2022 7 3.96 -43.43%
September 2022 4.9 8.91 81.84%
October 2022 8.82 5.94 -32.65%
November 2022 5.05 0 -100%
December 2022 0 0 -100%

Caladrius Biosciences Stock Forecast for 2023

January 2023 0 0 -100%
February 2023 0 0 -100%
March 2023 0 3 -100%
April 2023 3.06 9.9 223.53%
May 2023 12 14.85 23.75%
June 2023 15 9 -40%
July 2023 8 5.94 -25.75%
August 2023 6.12 3.03 -50.49%
September 2023 2.94 8.16 177.55%
October 2023 8 4.04 -49.5%
November 2023 3.96 0 -100%
December 2023 0 0 -100%

Caladrius Biosciences Stock Forecast for 2024

January 2024 0 0 -100%
February 2024 0 0 -100%
March 2024 0 2.04 -100%
April 2024 1.96 10.78 450%
May 2024 10.78 14 29.87%
June 2024 13.86 9.09 -34.42%
July 2024 8.16 3.92 -51.96%
August 2024 4.9 2.04 -58.37%
September 2024 4.08 6.86 68.14%
October 2024 7.07 3.03 -57.14%
November 2024 3.03 0 -100%
December 2024 0 0 -100%

Caladrius Biosciences Stock Forecast for 2025

January 2025 0 0 -100%
February 2025 0 0 -100%
March 2025 0 1.02 -100%
April 2025 1.01 9 791.09%
May 2025 10.2 13.26 30%
June 2025 12.74 7 -45.05%
July 2025 6.86 4.08 -40.52%
August 2025 4.04 0 -100%
September 2025 1.98 6.06 206.06%
October 2025 5.94 1.98 -66.67%
November 2025 2.04 0 -100%
December 2025 0 0 -100%

Caladrius Biosciences Stock Forecast for 2026

January 2026 0 0 -100%
February 2026 0 0 -100%
March 2026 0 0 -100%
April 2026 0 7.92 -100%
May 2026 8.82 13.26 50.34%
June 2026 12 6.12 -49%
July 2026 6 3.03 -49.5%
August 2026 2.97 0 -100%
September 2026 1.01 5 395.05%
October 2026 5.1 2.04 -60%
November 2026 0.98 0 -100%
December 2026 0 0 -100%

Caladrius Biosciences Stock Forecast for 2027

January 2027 0 0 -100%